Correction: The diagnostic value of miR-340-5p in pediatric ulcerative colitis and its molecular mechanism by targeting MAP3K2 to modulate intestinal epithelial cell dysfunction
Fanting Meng, Xianlong Han, Lingxia Ge, Nan Guan
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInflammatory Bowel Disease · Cancer Mechanisms and Therapy · NF-κB Signaling Pathways
Correction: Hereditas 162, 229 (2025)
https://doi.org/10.1186/s41065-025-00597-z
Following publication of the original article [1], the author reported that Figure 4 image and its caption is not the final version. Additionally, the header of Supplementary Table 1 needs to be updated from Table S2 to Table S1.
Incorrect Figure 4
Correct Figure 4
Fig. 4. Effects of miR-340-5p on DSS-induced inflammatory response and oxidative stress. A Levels of the inflammatory cytokine TNF-α under different treatments. B Levels of IL-6 under different treatments. C Levels of IL-17 under different treatments. D Levels of IL-1β under different treatments. E Levels of the oxidative index MDA under different treatments. F Levels of the antioxidant GSH under different treatments. G Levels of the oxidative index SOD under different treatments. H Levels of the antioxidant T-AOC under different treatments. ****P <0.0001, ***P <0.001, **P <0.01, n=3. ****P <0.0001, ****P *<0.001, **P <0.01, n=3
The original article has been updated.